by Jordana Choucair | Sep 27, 2022 | Life Sciences
Pfizer announced it asked the Food and Drug Administration (FDA) to approve its omicron-specific COVID-19 booster shot for children between the ages of 5 and 11. Pfizer asked the FDA to authorize a 10-microgram dose for children, one-third of the 30 microgram dose...
by Jordana Choucair | Sep 27, 2022 | Mental Health
A Bloomberg article explores how the mental health crisis has led hospitals to create a new kind of emergency unit. Developed at the University of California in Riverside, the Empath (emergency psychiatric assessment, treatment, and healing) centers improve care by...
by Jordana Choucair | Sep 26, 2022 | D.C. News
The Biden administration is set to launch a private refugee sponsorship program this Fall that will enlist private organizations and groups of everyday Americans to sponsor and resettle refugees. The program would first draw from the existing refugee pipeline –...
by Jordana Choucair | Sep 26, 2022 | Life Sciences
Moderna announced that it asked the Food and Drug Administration (FDA) to authorize its omicron booster shots for children. Moderna filed two separate FDA authorization requests, one for adolescents ages 12 to 17 and another for kids ages 6 to 11. The biotech company...
by Jordana Choucair | Sep 26, 2022 | Opioid/Substance Use Disorders
A FAIR Health analysis – released to Axios one day in advance of publication – shows the rising burden of substance use across the U.S. According to the study of private insurance claims, 42 states saw an increase in the proportion of patients with opioid and...
Recent Comments